Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hoarseness, a Major Presenting Symptom in a Patient With Multiple Sclerosis



Shaygannejad V1 ; Kazemi M1 ; Okhovat A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Otolaryngology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2008

Abstract

Multiple sclerosis (MS) is a chronic neurological disease with different presenting symptoms. We introduce a case of MS presented with hoarseness. A 38-year-old man complaining of hoarseness was referred to our clinic for a sudden palsy of right IX and X cranial nerves. Neurological examination showed signs of right IX and X cranial nerves paralyses, hoarseness, fine unidirectional horizontal nystagmus to the left and bilateral loss of cutaneous abdominal reflexes. Brain MRI revealed McDonald criteria for diagnosing MS. Pulse therapy was started and he recovered in 2 months. Beta interferon 1a began for him and in 9 months follow up, no relapse occurred.
Related Docs
View other Related Docs
1. Co-Occurrence of Multiple Sclerosis and Thomsen’S Myotonia: A Report of Two Cases, Functional Neurology (2014)
2. Complete Horizontal Gaze Palsy Due to Bilateral Paramedian Pontine Reticular Formation Involvement As a Presentation of Multiple Sclerosis: A Case Report, BMC Neurology (2019)
3. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
4. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
5. Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients, International Journal of Preventive Medicine (2023)
6. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
7. Tumefactive Rebound of Multiple Sclerosis After the Short-Term Cessation of Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2020)
8. Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases, Journal of Central Nervous System Disease (2024)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (30)
Vahid Shaygannejad (17)
Other Related Docs
9. Prevalence of Hypothyroidism Among Patients With Multiple Sclerosis Referred to Multiple Sclerosis Clinic of Alzahra Hospital, Isfahan, Iran, During 2014-2015, Journal of Isfahan Medical School (2016)
10. Designing of an Elisa Method for the Measurement of Serum Antibodies Against Interferon-Beta and the Study of the Frequency of These Antibodies in Patients With Multiple Sclerosis Treated With Cinnovex, Journal of Isfahan Medical School (2012)
11. Investigating the Occurrence of Femoral Head Avascular Necrosis in Patient With Multiple Sclerosis Treated With Interferon-Beta, Journal of Isfahan Medical School (2018)
12. Concurrent Glioma and Multiple Sclerosis: A Systematic Review of Case Reports, Multiple Sclerosis and Related Disorders (2024)
13. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
14. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
15. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
16. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
17. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
18. Side Effects of Methylprednisolone Pulse Therapy in Treatment of Multiple Sclerosis, Journal of Isfahan Medical School (2012)
19. Pure Spinal Multiple Sclerosis: A Case Series of a Possible New Entity, Journal of Neuroimmunology (2025)
20. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
21. Myasthenia Gravis During the Course of Neuromyelitis Optica, Case Reports in Neurology (2011)
22. Comparing Side Effects of Cinnovex With Avonex in Relapsing Remitting Multiple Sclerosis Patients, Journal of Isfahan Medical School (2009)
23. Prevalence of Dysphagia in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2023)
24. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
25. False Diagnosis in Multiple Sclerosis, Pakistan Journal of Medical Sciences (2013)
26. Management of Seizures in Patients With Multiple Sclerosis; an Iranian Consensus, Epilepsy and Behavior (2019)
27. Mri Signs of Cns Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2021)
28. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
29. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
30. Childhood-Onset Multiple Sclerosis: Report of 82 Patients From Isfahan, Iran, Archives of Iranian Medicine (2007)
31. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients, Journal of Child Neurology (2016)
32. The Epidemiologic and Demographic Characteristics and Clinical Findings in Patients With Acute Disseminated Encephalomyelitis (Adem) Referred to Alzahra Hospital, Isfahan, Iran, During 10 Years (2003-2013), Journal of Isfahan Medical School (2015)
33. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
34. Facial Involvement in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
35. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
36. Linkage of Multiple Sclerosis and Guillain-Barre Syndrome: A Population-Based Survey in Isfahan, Iran, Autoimmune Diseases (2012)
37. Headache in Radiologically Isolated Syndrome: A Hint Toward Imminent Conversion: A Case Report, Journal of Medical Case Reports (2025)
38. Balo Concentric Sclerosis, an Emerging Variant of Multiple Sclerosis: A Case-Series and Literature Review, Journal of Neuroimmunology (2025)
39. Oropharyngeal Dysphagia in Multiple Sclerosis, Multiple Sclerosis (2010)
40. Seizure Characteristics in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)
41. Adverse Reaction of Methylprednisolone Pulse Therapy: Acute Respiratory Distress Syndrome, Clinical Case Reports (2021)
42. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy, Cell Journal (2017)
43. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
44. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2022)
45. Pediatric Multiple Sclerosis With Primary Progressive Course-Report of a Retrospective Cohort Study in Iran, Neuropediatrics (2013)
46. Number and Volume of Demyelinative Plaques Can Predict the Response to Treatment in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2011)
47. Jacksonian Seizure As the Relapse Symptom of Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
48. Rapid Exacerbation of Multiple Sclerosis Following the Initiation of Interferon-Β: Report of Nine Cases, Journal of Research in Medical Sciences (2011)
49. Characteristics of Familial Multiple Sclerosis in Isfahan, Iran: A Cross-Sectional Study, Neurology Asia (2014)
50. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)